loadpatents
Patent applications and USPTO patent grants for Fischer; Peter Martin.The latest application filed is for "novel cyclic phenoxy compounds and improved treatments for cardiac and cardiovascular disease".
Patent | Date |
---|---|
Novel Cyclic Phenoxy Compounds and Improved Treatments for Cardiac and Cardiovascular Disease App 20150051270 - Mistry; Shailesh ;   et al. | 2015-02-19 |
Purine derivatives Grant 8,846,696 - Fischer , et al. September 30, 2 | 2014-09-30 |
Phenoxypropanol Derivatives And Their Use In Treating Cardiac And Cardiovascular Diseases App 20130261178 - Mistry; Shailesh ;   et al. | 2013-10-03 |
4-arylazo-3,5-diamino-pyrazole compounds and use thereof Grant 8,357,673 - Cankar , et al. January 22, 2 | 2013-01-22 |
Pyrimidines, Triazines And Their Use As Pharmaceutical Agents App 20110092490 - Wang; Shudong ;   et al. | 2011-04-21 |
Pyrimidin-4-yl-3, 4-thione compounds and their use in therapy Grant 7,902,361 - Wang , et al. March 8, 2 | 2011-03-08 |
Pyrimidine compounds Grant 7,897,605 - Wang , et al. March 1, 2 | 2011-03-01 |
New Purine Derivatives App 20090325983 - FISCHER; Peter Martin ;   et al. | 2009-12-31 |
4-(1H-Indol-3-yl)-Pyrimidin-2-Ylamine Derivatives and Their Use in Therapy App 20090318446 - Fischer; Peter Martin ;   et al. | 2009-12-24 |
2,6,9-substituted purine derivatives and their use in the treatment of proliferative disorders Grant 7,612,079 - Fischer , et al. November 3, 2 | 2009-11-03 |
Purine derivatives Grant 7,582,642 - Fischer , et al. September 1, 2 | 2009-09-01 |
4-Heteroaryl Pyrimidine Derivatives and use thereof as Protein Kinase Inhibitors App 20090215805 - Wood; Gavin ;   et al. | 2009-08-27 |
Thiazolo-, oxazalo and imidazolo-quinazoline compounds capable of inhibiting protein kinases Grant 7,576,091 - McInnes , et al. August 18, 2 | 2009-08-18 |
Purine derivatives Grant 7,544,689 - Fischer , et al. June 9, 2 | 2009-06-09 |
2-substituted-4-heteroaryl-pyrimidines useful for the treatment of proliferative disorders App 20090137572 - Wang; Shudong ;   et al. | 2009-05-28 |
Compounds App 20080318954 - Duncan; Kenneth ;   et al. | 2008-12-25 |
4-Arylazo-3,5-Diamino-Pyrazole Compounds and Use Thereof App 20080312238 - Cankar; Petr ;   et al. | 2008-12-18 |
Pyrimidine compounds App 20080287439 - Wang; Shudong ;   et al. | 2008-11-20 |
p21 peptides Grant 7,449,544 - Zheleva , et al. November 11, 2 | 2008-11-11 |
Pyrimidine compounds Grant 7,432,260 - Wang , et al. October 7, 2 | 2008-10-07 |
N-(4-(4-methylthiazol-5-yl) pyrimidin-2-yl)-N-phenylamines as antiproliferative compounds Grant 7,427,627 - Wang , et al. September 23, 2 | 2008-09-23 |
Crystal Structure of Human Proliferating Cell Nuclear Antigen (Pcna) and Uses Thereof App 20080167385 - Kontopidis; George ;   et al. | 2008-07-10 |
N-(4-(4-methylthiazol-5-yl)pyrimidin-2-yl)-N-phenylamines as antiproliferative compounds Grant 7,388,015 - Wang , et al. June 17, 2 | 2008-06-17 |
Method for Identifying Inhibitors Using a Homology Model of Polo-Like Kinase 1 App 20080132484 - McInnes; Campbell ;   et al. | 2008-06-05 |
Medicament Grant 7,312,356 - Fischer , et al. December 25, 2 | 2007-12-25 |
Inhibitors of cyclin dependent kinases as anti-cancer agent Grant 7,262,202 - Fischer , et al. August 28, 2 | 2007-08-28 |
Inhibitors of cyclin dependent kinases as anti-cancer agent App 20070185134 - Fischer; Peter Martin ;   et al. | 2007-08-09 |
Pyrimidin-4-YL-3, 4-thione compounds and their use in therapy App 20070021452 - Wang; Shudong ;   et al. | 2007-01-25 |
2-Aminophenyl-4-phenylpyrimidines as kinase inhibitors App 20070021419 - Wang; Shudong ;   et al. | 2007-01-25 |
P21 derived peptides and uses thereof App 20060293245 - Zheleva; Daniella I. ;   et al. | 2006-12-28 |
Cyclin groove inhibitors App 20060281687 - Andrews; Martin J.I. ;   et al. | 2006-12-14 |
Thiazolo-, oxazalo and imidazolo-quinazoline compounds capable of inhibiting protein kinases App 20060264628 - McInnes; Campbell ;   et al. | 2006-11-23 |
Pyridinylamino-pyrimidine derivatives as protein kinase inhibitors App 20060241297 - Wang; Shudong ;   et al. | 2006-10-26 |
N-(4-(4-methylthiazol-5-yl) pyrimidin-2-yl)-N-phenylamines as antiproliferative compounds App 20060199830 - Wang; Shudong ;   et al. | 2006-09-07 |
Transport vectors Grant 7,101,967 - Fischer , et al. September 5, 2 | 2006-09-05 |
New purine derivatives App 20060183760 - Fischer; Peter Martin ;   et al. | 2006-08-17 |
Benzthiazole-3 oxides useful for the treatment of proliferative disorders App 20060040997 - McInnes; Campbell ;   et al. | 2006-02-23 |
Anti-viral compounds App 20050288307 - Wang, Shudong ;   et al. | 2005-12-29 |
Therapeutic applications of 2-substituted 4-heteroarylpyrimidines App 20050282843 - Wang, Shudong ;   et al. | 2005-12-22 |
CDK2/cyclin A crystals and uses thereof App 20050260730 - Fischer, Peter Martin | 2005-11-24 |
New purine derivatives App 20050256142 - Fischer, Peter Martin ;   et al. | 2005-11-17 |
Bisarylsulfonamide compounds and their use in cancer therapy App 20050215548 - Wang, Shudong ;   et al. | 2005-09-29 |
Pyrimidine compounds App 20050192300 - Wang, Shudong ;   et al. | 2005-09-01 |
Medicament App 20050159484 - Fischer, Peter Martin ;   et al. | 2005-07-21 |
p21 peptides App 20050153894 - Zheleva, Daniella I. ;   et al. | 2005-07-14 |
2,6,9-Substituted purine derivatives and their use in the treatment of proliferative disorders App 20050009846 - Fischer, Peter Martin ;   et al. | 2005-01-13 |
N-(4-(4-methylthiazol-5-yl)pyrimidin-2-yl)-N-phenylamines as antiproliferative compounds App 20040259894 - Wang, Shudong ;   et al. | 2004-12-23 |
Inhibitors of cyclin dependent kinases as anti-cancer agent App 20040132746 - Fischer, Peter Martin ;   et al. | 2004-07-08 |
Transport vectors App 20020098236 - Fischer, Peter Martin ;   et al. | 2002-07-25 |
Hemoregulatory peptides for stimulating the myelopoietic system Grant 5,830,867 - Bhatnagar , et al. November 3, 1 | 1998-11-03 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.